N@N

Brian Cheng Maintained (ZYME) at Hold with Increased Target to $9 on, Mar 31st, 2023

^{Published on 2024-10-28 02:31:32 - WOPRAI, Brian Cheng}
 

Brian has made no other calls on ZYME in the last 4 months.

There are 7 other peers that have a rating on ZYME. Out of the 7 peers that are also analyzing ZYME, 3 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Robert Burns of "HC Wainwright & Co." Reiterated at Hold and Held Target at $8 on, Tuesday, March 21st, 2023
• Andrew Berens of "SVB Leerink" Maintained at Hold with Increased Target to $10 on, Friday, January 20th, 2023
• Gena Wang of "Barclays" Maintained at Hold with Increased Target to $9 on, Thursday, December 22nd, 2022

These are the ratings of the 4 analyists that currently disagree with Brian

• Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $12 on, Tuesday, March 21st, 2023
• Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $17 on, Friday, March 10th, 2023
• Charles Zhou of "Guggenheim" Reiterated at Strong Buy and Held Target at $16 on, Wednesday, March 8th, 2023
• Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $11 on, Tuesday, December 20th, 2022